金迪克：聘任张良斌先生为公司总经理

Group 1 - The company announced the appointment of Mr. Zhang Liangbin as the new General Manager, effective from the date of the board meeting approval until the end of the second board term [1] - Mr. Zhang Liangbin resigned from his position as a member of the Audit Committee due to adjustments in the company's governance structure, but will continue to serve as a director and General Manager [1] - The board approved the election of Mr. Nie Shenqian as a member of the Audit Committee for the second board [1] Group 2 - The company's revenue composition for the year 2024 is 100% from biopharmaceuticals [1] - The current market capitalization of the company is 3.1 billion yuan [2]